These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 6407551

  • 1. Chelation in metal intoxication. XIII. Polyaminocarboxylic acids as chelators in lead poisoning.
    Tandon SK, Behari JR, Singh S.
    Bull Environ Contam Toxicol; 1983 May; 30(5):552-8. PubMed ID: 6407551
    [No Abstract] [Full Text] [Related]

  • 2. Chelation in metal intoxication XXI: Chelation in lead intoxication during vitamin B complex deficiency.
    Tandon SK, Flora SJ, Singh S.
    Bull Environ Contam Toxicol; 1986 Sep; 37(3):317-25. PubMed ID: 3017483
    [No Abstract] [Full Text] [Related]

  • 3. [Recent advance in the therapy of metal poisoning with complexing agents].
    Aaseth J.
    Tidsskr Nor Laegeforen; 1972 May 10; 12(13):918-22. PubMed ID: 4624035
    [No Abstract] [Full Text] [Related]

  • 4. Mobilization and distribution of beryllium over the course of chelation therapy with some polyaminocarboxylic acids in the rat.
    Mathur S, Flora SJ, Mathur R, Das Gupta S.
    Hum Exp Toxicol; 1993 Jan 10; 12(1):19-24. PubMed ID: 8094965
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the antidotal efficacy of polyamincarboxylic acids (CDTA and DTPA) with time after acute zinc poisoning.
    Llobet JM, Colomina MT, Domingo JL, Corbella J.
    Vet Hum Toxicol; 1989 Feb 10; 31(1):25-8. PubMed ID: 2496518
    [Abstract] [Full Text] [Related]

  • 6. Unanswered questions in metal chelation.
    Kosnett MJ.
    J Toxicol Clin Toxicol; 1992 Feb 10; 30(4):529-47. PubMed ID: 1331492
    [No Abstract] [Full Text] [Related]

  • 7. Clinical uses of metal-binding drugs.
    Chenoweth MB.
    Clin Pharmacol Ther; 1968 Feb 10; 9(3):365-87. PubMed ID: 4984845
    [No Abstract] [Full Text] [Related]

  • 8. Lead elimination of ICRF 158 in rats after chronic lead exposure.
    Witting U, Hultsch E.
    Int Arch Occup Environ Health; 1981 Feb 10; 48(1):89-98. PubMed ID: 6783552
    [Abstract] [Full Text] [Related]

  • 9. Treatment of chronic lead intoxication.
    Sanchez-Fructuoso AI, Prats D, Barrientos A.
    Ann Intern Med; 1999 Nov 02; 131(9):716. PubMed ID: 10577344
    [No Abstract] [Full Text] [Related]

  • 10. [On the chelating action of CaDTPA Na3 (trisodic and monocalcic salt of ethylen-triaminopentacetic acid) in experimental and human saturnism and in compairison with the action of CaEDTANa2].
    Rossi A.
    Folia Med (Napoli); 1967 Jan 02; 50(1):39-51. PubMed ID: 4972289
    [No Abstract] [Full Text] [Related]

  • 11. [Experimental contribution on the question of lead decorporation by chelating agents].
    Catsch A.
    Arzneimittelforschung; 1967 Apr 02; 17(4):493-5. PubMed ID: 5632447
    [No Abstract] [Full Text] [Related]

  • 12. Antagonists for acute oral cadmium chloride intoxication.
    Basinger MA, Jones MM, Holscher MA, Vaughn WK.
    J Toxicol Environ Health; 1988 Apr 02; 23(1):77-89. PubMed ID: 2826797
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats.
    Flora SJ, Tandon SK.
    Toxicology; 1990 Nov 02; 64(2):129-39. PubMed ID: 2171159
    [Abstract] [Full Text] [Related]

  • 14. Reversible hypothyroidism with EDTA chelation therapy in a patient with elevated lead burden and chronic renal insufficiency.
    Lin JL, Shih FC.
    Nephrol Dial Transplant; 1997 Feb 02; 12(2):364-5. PubMed ID: 9132667
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of acute lead intoxication--choice of chelating agents and supportive therapeutic measures.
    Chisolm JJ.
    Clin Toxicol; 1970 Dec 02; 3(4):527-40. PubMed ID: 4999705
    [No Abstract] [Full Text] [Related]

  • 16. Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice.
    Jones MM, Basinger MA, Gale GR, Atkins LM, Smith AB, Stone A.
    Toxicology; 1994 Apr 18; 89(2):91-100. PubMed ID: 8197593
    [Abstract] [Full Text] [Related]

  • 17. Decreased effectiveness of chelation therapy with time after acute cadmium poisoning.
    Cantilena LR, Klaassen CD.
    Toxicol Appl Pharmacol; 1982 Apr 18; 63(2):173-80. PubMed ID: 6283691
    [No Abstract] [Full Text] [Related]

  • 18. Chelation therapy in workers exposed to lead. A critical review.
    Lilis R, Fischbein A.
    JAMA; 1976 Jun 28; 235(26):2823-4. PubMed ID: 819666
    [No Abstract] [Full Text] [Related]

  • 19. Computer simulation of metal ion equilibria in biofluids. IV. Plutonium speciation in human blood plasma and chelation therapy using polyaminopolycarboxylic acids.
    Duffield JR, May PM, Williams DR.
    J Inorg Biochem; 1984 Mar 28; 20(3):199-214. PubMed ID: 6425458
    [Abstract] [Full Text] [Related]

  • 20. Influence of chelation therapy on acute lead intoxication in rats.
    Hofmann U, Segewitz G.
    Arch Toxicol; 1975 Nov 20; 34(3):213-25. PubMed ID: 1243621
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.